Funds holding FULCRUM THERAPEUTICS INC
ISIN US3596161097 · United States
- Fund holders
- 149
- Of which ETFs
- 30 119 other funds
- Value held
- 49.5M $
- Share of capital
- 15.4 % of 76.3M shares on Jul 23, 2026
| Fund | Shares | Value | Weight in fund | Share of capital | |
|---|---|---|---|---|---|
| Invesco Nasdaq Biotechnology ETF Invesco Exchange-Traded Fund Trust II | 3,501 | 24.2K $ | 0.04 % | 0.00 % | as of May 31, 2026 ↗ |
| VIP Extended Market Index Portfolio Variable Insurance Products Fund II | 3,500 | 12.8K $ | 0.00 % | 0.00 % | as of Jun 30, 2026 ↗ |
| Blackstone Alternative Multi-Strategy Fund Blackstone Alternative Investment Funds | 3,200 | 11.7K $ | 0.00 % | 0.00 % | as of Jun 30, 2026 ↗ |
| LVIP Dimensional U.S. Core Equity 2 Fund LINCOLN VARIABLE INSURANCE PRODUCTS TRUST | 3,143 | 11.5K $ | 0.00 % | 0.00 % | as of Jun 30, 2026 ↗ |
| Small-Cap Equity Portfolio PACIFIC SELECT FUND | 3,067 | 11.2K $ | 0.00 % | 0.00 % | as of Jun 30, 2026 ↗ |
| ProShares Russell 2000 High Income ETF ProShares Trust | 2,817 | 19.5K $ | 0.01 % | 0.00 % | as of May 31, 2026 ↗ |
| THRIVENT MODERATELY AGGRESSIVE ALLOCATION PORTFOLIO Thrivent Series Fund, Inc. | 2,816 | 10.3K $ | 0.00 % | 0.00 % | as of Jun 30, 2026 ↗ |
| Strategic Equity Allocation Trust John Hancock Variable Insurance Trust | 2,527 | 9.2K $ | 0.00 % | 0.00 % | as of Jun 30, 2026 ↗ |
| ProShares Ultra Nasdaq Biotechnology ProShares Trust | 2,464 | 17.1K $ | 0.02 % | 0.00 % | as of May 31, 2026 ↗ |
| THRIVENT MODERATE ALLOCATION PORTFOLIO Thrivent Series Fund, Inc. | 2,335 | 8.5K $ | 0.00 % | 0.00 % | as of Jun 30, 2026 ↗ |
| JNL/DFA U.S. Core Equity Fund JNL Series Trust | 2,262 | 8.3K $ | 0.00 % | 0.00 % | as of Jun 30, 2026 ↗ |
| ProShares UltraPro Russell2000 ProShares Trust | 2,227 | 15.4K $ | 0.00 % | 0.00 % | as of May 31, 2026 ↗ |
| Morgan Stanley Pathway Small-Mid Cap Equity ETF MORGAN STANLEY PATHWAY FUNDS | 2,209 | 15.3K $ | 0.00 % | 0.00 % | as of May 31, 2026 ↗ |
| ProShares Ultra Russell2000 ProShares Trust | 2,203 | 15.2K $ | 0.01 % | 0.00 % | as of May 31, 2026 ↗ |
| iShares Total U.S. Stock Market Index Fund BlackRock Funds | 1,951 | 7K $ | 0.00 % | 0.00 % | as of Jul 31, 2026 ↗ |
| THRIVENT MODERATELY AGGRESSIVE ALLOCATION FUND Thrivent Mutual Funds | 1,938 | 6.9K $ | 0.00 % | 0.00 % | as of Jul 31, 2026 ↗ |
| Nationwide Fundamental All Cap Equity Portfolio Nationwide Mutual Funds | 1,658 | 5.9K $ | 0.00 % | 0.00 % | as of Jul 31, 2026 ↗ |
| EQ/Franklin Small Cap Value Managed Volatility Portfolio EQ Advisors Trust | 1,591 | 5.8K $ | 0.00 % | 0.00 % | as of Jun 30, 2026 ↗ |
| THRIVENT AGGRESSIVE ALLOCATION FUND Thrivent Mutual Funds | 1,450 | 5.2K $ | 0.00 % | 0.00 % | as of Jul 31, 2026 ↗ |
| Penn Series Small Cap Index Fund Penn Series Funds Inc | 1,400 | 5.1K $ | 0.01 % | 0.00 % | as of Jun 30, 2026 ↗ |
| Destinations Small-Mid Cap Equity Fund Brinker Capital Destinations Trust | 1,233 | 8.5K $ | 0.00 % | 0.00 % | as of May 31, 2026 ↗ |
| THRIVENT AGGRESSIVE ALLOCATION PORTFOLIO Thrivent Series Fund, Inc. | 1,228 | 4.5K $ | 0.00 % | 0.00 % | as of Jun 30, 2026 ↗ |
| State Street Total Return V.I.S. Fund STATE STREET VARIABLE INSURANCE SERIES FUNDS INC | 1,165 | 4.3K $ | 0.00 % | 0.00 % | as of Jun 30, 2026 ↗ |
| VIP Total Market Index Portfolio Variable Insurance Products Fund II | 1,152 | 4.2K $ | 0.00 % | 0.00 % | as of Jun 30, 2026 ↗ |
| Total Stock Market Index Trust John Hancock Variable Insurance Trust | 1,142 | 4.2K $ | 0.00 % | 0.00 % | as of Jun 30, 2026 ↗ |
| Bridge Builder Small/Mid Cap Growth Fund Bridge Builder Trust | 941 | 3.4K $ | 0.00 % | as of Jun 30, 2026 ↗ | |
| THRIVENT MODERATE ALLOCATION FUND Thrivent Mutual Funds | 938 | 3.4K $ | 0.00 % | 0.00 % | as of Jul 31, 2026 ↗ |
| THRIVENT GLOBAL STOCK FUND Thrivent Mutual Funds | 843 | 3K $ | 0.00 % | 0.00 % | as of Jul 31, 2026 ↗ |
| Nuveen Life Stock Index Fund TIAA-CREF Life Funds | 800 | 2.9K $ | 0.00 % | 0.00 % | as of Jun 30, 2026 ↗ |
| THRIVENT MODERATELY CONSERVATIVE ALLOCATION PORTFOLIO Thrivent Series Fund, Inc. | 796 | 2.9K $ | 0.00 % | 0.00 % | as of Jun 30, 2026 ↗ |
| ULTRA SMALL CAP PROFUND ProFunds | 764 | 2.7K $ | 0.00 % | 0.00 % | as of Jul 31, 2026 ↗ |
| THRIVENT GLOBAL STOCK PORTFOLIO Thrivent Series Fund, Inc. | 697 | 2.6K $ | 0.00 % | 0.00 % | as of Jun 30, 2026 ↗ |
| Avantis U.S. Equity Fund American Century ETF Trust | 653 | 4.5K $ | 0.00 % | 0.00 % | as of May 31, 2026 ↗ |
| Knights of Columbus U.S. ALL CAP INDEX FUND ADVISORS' INNER CIRCLE III | 377 | 1.3K $ | 0.00 % | 0.00 % | as of Jul 31, 2026 ↗ |
| Dimensional VA U.S. Targeted Value Portfolio DFA INVESTMENT DIMENSIONS GROUP INC | 344 | 1.2K $ | 0.00 % | 0.00 % | as of Jul 31, 2026 ↗ |
| Russell 2000 2x Strategy Fund Rydex Dynamic Funds | 319 | 1.2K $ | 0.00 % | 0.00 % | as of Jun 30, 2026 ↗ |
| Wilshire 5000 Index Fund Wilshire Mutual Funds Inc | 295 | 1.1K $ | 0.00 % | 0.00 % | as of Jun 30, 2026 ↗ |
| Fidelity Enhanced Small Cap Growth ETF Fidelity Covington Trust | 255 | 933.3 $ | 0.02 % | 0.00 % | as of Jun 30, 2026 ↗ |
| PROFUND VP ULTRA SMALL CAP ProFunds | 244 | 893 $ | 0.00 % | 0.00 % | as of Jun 30, 2026 ↗ |
| Fidelity Enhanced Small Cap Value ETF Fidelity Covington Trust | 205 | 750.3 $ | 0.01 % | 0.00 % | as of Jun 30, 2026 ↗ |
| PROFUND VP SMALL CAP ProFunds | 159 | 581.9 $ | 0.01 % | 0.00 % | as of Jun 30, 2026 ↗ |
| Russell 2000 Fund Rydex Series Funds | 147 | 538 $ | 0.00 % | 0.00 % | as of Jun 30, 2026 ↗ |
| THRIVENT MODERATELY CONSERVATIVE ALLOCATION FUND Thrivent Mutual Funds | 133 | 476.1 $ | 0.00 % | as of Jul 31, 2026 ↗ | |
| Columbia Research Enhanced Small Cap ETF Columbia ETF Trust I | 97 | 355 $ | 0.01 % | 0.00 % | as of Jun 30, 2026 ↗ |
| Russell 2000 1.5x Strategy Fund Rydex Series Funds | 88 | 322.1 $ | 0.00 % | 0.00 % | as of Jun 30, 2026 ↗ |
| ProShares Hedge Replication ETF ProShares Trust | 56 | 387.5 $ | 0.00 % | 0.00 % | as of May 31, 2026 ↗ |
| SMALL-CAP PROFUND ProFunds | 50 | 179 $ | 0.00 % | 0.00 % | as of Jul 31, 2026 ↗ |
| ProShares Russell 2000 Dynamic Buffer ETF ProShares Trust | 17 | 117.6 $ | 0.01 % | 0.00 % | as of May 31, 2026 ↗ |
| Russell 2000(R) 1.5x Strategy Fund Rydex Variable Trust | 17 | 62.2 $ | 0.00 % | 0.00 % | as of Jun 30, 2026 ↗ |
The funds most exposed to it
The weight is the share of a fund's net assets. The holders table ranks funds by number of shares. This one ranks them by the weight of the company in each fund.
| Fund | Weight in fund | |
|---|---|---|
| State Street(R) SPDR(R) S&P(R) Pharmaceuticals ETF SPDR SERIES TRUST | 0.69 % | as of Jun 30, 2026 ↗ |
| PROFUND VP PHARMACEUTICALS ProFunds | 0.67 % | as of Jun 30, 2026 ↗ |
| Direxion Daily Pharmaceutical & Medical Bull 3X Shares Direxion Shares ETF Trust | 0.50 % | as of Jul 31, 2026 ↗ |
| PHARMACEUTICALS ULTRASECTOR PROFUND ProFunds | 0.47 % | as of Jul 31, 2026 ↗ |
| Simplify Health Care ETF Simplify Exchange Traded Funds | 0.16 % | as of Jun 30, 2026 ↗ |
| AVIP BlackRock Advantage Small Cap Growth Portfolio AuguStar Variable Insurance Products Fund Inc | 0.06 % | as of Jun 30, 2026 ↗ |
| BlackRock Advantage Small Cap Growth Fund BlackRock Funds | 0.06 % | as of Jun 30, 2026 ↗ |
| BlackRock Advantage Small Cap Core Fund BlackRock Funds | 0.05 % | as of May 29, 2026 ↗ |
| BlackRock Advantage SMID Cap V.I. Fund BlackRock Variable Series Funds, Inc. | 0.05 % | as of Jun 30, 2026 ↗ |
| iShares Micro-Cap ETF iShares Trust | 0.05 % | as of Jun 30, 2026 ↗ |
Quarter after quarter
Each row is one quarter of SEC filings, newest first. The change compares each quarter with the one before.
| Quarter | Holders | Change | Shares | Change |
|---|---|---|---|---|
| 2026Q3 | 149 | -3 | 11,772,445 | +13.1 % |
| 2026Q2 | 152 | +12 | 10,410,521 | +18.7 % |
| 2026Q1 | 140 | +2 | 8,768,459 | +0.5 % |
| 2025Q4 | 138 | 0 | 8,721,489 | -7.4 % |
| 2025Q3 | 138 | +3 | 9,420,019 | -2.4 % |
| 2025Q2 | 135 | +2 | 9,650,230 | -9.2 % |
| 2025Q1 | 133 | -12 | 10,631,577 | -23.8 % |
| 2024Q4 | 145 | +59 | 13,949,005 | +26.1 % |
| 2024Q3 | 86 | +20 | 11,066,083 | +8.7 % |
| 2024Q2 | 66 | +8 | 10,182,368 | +6.4 % |
| 2024Q1 | 58 | +2 | 9,568,794 | +0.7 % |
| 2023Q4 | 56 | 9,503,669 |
Institutional managers
163 managers declare this company to the SEC (Form 13F). The table shows the 25 largest.
| Manager | Shares | Value | |
|---|---|---|---|
| SUVRETTA CAPITAL MANAGEMENT, LLC | 6,561,111 | 50.3M $ | as of Mar 31, 2026 |
| RA CAPITAL MANAGEMENT, L.P. | 6,053,960 | 46.4M $ | as of Mar 31, 2026 |
| BlackRock, Inc. | 5,390,593 | 41.3M $ | as of Mar 31, 2026 |
| TCG Crossover Management, LLC | 5,250,000 | 40.3M $ | as of Mar 31, 2026 |
| BRAIDWELL LP | 3,134,922 | 24M $ | as of Mar 31, 2026 |
| Nantahala Capital Management, LLC | 3,050,040 | 23.4M $ | as of Mar 31, 2026 |
| Siren, L.L.C. | 2,350,000 | 18M $ | as of Mar 31, 2026 |
| First Turn Management, LLC | 2,256,109 | 17.3M $ | as of Mar 31, 2026 |
| Aberdeen Group plc | 2,211,953 | 17M $ | as of Mar 31, 2026 |
| Point72 Asset Management, L.P. | 2,074,855 | 15.9M $ | as of Mar 31, 2026 |
| GSK plc | 1,785,714 | 13.7M $ | as of Mar 31, 2026 |
| Balyasny Asset Management L.P. | 1,779,946 | 13.7M $ | as of Mar 31, 2026 |
| Jones Hill Capital LP | 1,771,926 | 13.6M $ | as of Mar 31, 2026 |
| D. E. Shaw & Co., Inc. | 1,623,281 | 12.5M $ | as of Mar 31, 2026 |
| STATE STREET CORP | 1,549,851 | 11.9M $ | as of Mar 31, 2026 |
| GEODE CAPITAL MANAGEMENT, LLC | 1,486,542 | 11.4M $ | as of Mar 31, 2026 |
| Alyeska Investment Group, L.P. | 1,328,449 | 10.2M $ | as of Mar 31, 2026 |
| CITADEL ADVISORS LLC | 1,292,486 | 9.9M $ | as of Mar 31, 2026 |
| Assenagon Asset Management S.A. | 1,193,873 | 9.2M $ | as of Mar 31, 2026 |
| DIMENSIONAL FUND ADVISORS LP | 1,130,281 | 8.7M $ | as of Mar 31, 2026 |
| Vestal Point Capital, LP | 1,100,000 | 8.4M $ | as of Mar 31, 2026 |
| Ikarian Capital, LLC | 1,049,161 | 8M $ | as of Mar 31, 2026 |
| Qube Research & Technologies Ltd | 974,739 | 7.5M $ | as of Mar 31, 2026 |
| Connor, Clark & Lunn Investment Management Ltd. | 736,684 | 5.7M $ | as of Mar 31, 2026 |
| ACADIAN ASSET MANAGEMENT LLC | 727,315 | 5.6K $ | as of Mar 31, 2026 |
Declared shareholders of FULCRUM THERAPEUTICS INC
There are 8 beneficial ownership filings. These stakes do not add up. An asset manager that files includes its own funds, which already appear among the funds on this page.
| Shareholder | Declared stake | Shares | |
|---|---|---|---|
| TANG CAPITAL MANAGEMENT, LLC and 5 others | 10.40 % | 6,913,329 | as of Jul 13, 2026 · SCHEDULE 13G |
| Nantahala Capital Management, LLC and 2 others | 8.22 % | 5,475,040 | as of Jun 30, 2026 · SCHEDULE 13G |
| BlackRock, Inc. | 7.20 % | 4,802,880 | as of Jun 30, 2026 · SCHEDULE 13G |
| BANK OF AMERICA CORP /DE/ | 6.70 % | 4,468,123 | as of Jun 30, 2026 · SCHEDULE 13G |
| BlackRock Portfolio Management LLC | 6.00 % | 4,021,379 | as of Jun 30, 2026 · SCHEDULE 13G |
| Montanova Capital, LLC and 2 others | 5.50 % | 3,680,921 | as of Jun 30, 2026 · SCHEDULE 13G |
| RA Capital Management, L.P. and 3 others | 0.00 % | 0 | as of Jun 30, 2026 · SCHEDULE 13G |
| TCG Crossover GP II, LLC and 2 others | 0.00 % | 0 | as of Jun 30, 2026 · SCHEDULE 13G |
Cite this page
Titelia. "Funds holding FULCRUM THERAPEUTICS INC". https://titelia.com/en/stocks/fulcrum-therapeutics-inc-US3596161097